Based on these studies, we first found that MSI2 was expressed at higher levels than normal tissues in many tumors, such as lung, breast, and colon cancers, and especially in all types of NSCLC than in normal lung tissues by bioinformatics analysis. This evidence concerns the gene MSI2 and colonic neoplasm.